fda warning compounded semaglutide safety 2024 2025 Have patients been harmed by unsafe drug compounding? – Partnership for Safe Medicines Beyond the Headlines: FDA Warning

For patients who have heard about retatrutide liver fat reduction and are interested in its potential relevance to their own health, an informed conversation with their GP or specialist is the most appropriate first step

I think access is critically important, Cook adds

It not only curbs appetite and slows gastric emptying like semaglutide but also improves insulin sensitivity and supports more comprehensive metabolic health

Levitan I, Volkov S, Subbaiah PV

In STEP-1 (Wilding et al., NEJM 2021), 68 weeks of once-weekly 2.4 mg semaglutide plus lifestyle intervention produced a mean body-weight reduction of about 15%, versus about 2.4% with placebo a large, clinically meaningful, well-replicated effect

Always seek advice from your healthcare provider if youre experiencing unpleasant side effects